Literature DB >> 25225082

Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review.

Chun Cao1, Ting Liu2, Huanling Zhu2, Lin Wang3, Shen Kai2, Bing Xiang4.   

Abstract

Entities:  

Keywords:  Chemotherapy; Epstein-Barr virus-encoded small RNA-negative; Human immunodeficiency virus-negative; Interphase fluorescence in situ hybridization; Non-hodgkin lymphoma

Mesh：

Substances：

Year:  2014        PMID： 25225082     DOI： 10.1016/j.clml.2014.03.002

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  13 in total

1.  Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.

Authors:  Toshiki Yamada; Takeshi Hara; Naoe Goto; Hitoshi Iwata; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2019-03-11       Impact factor: 2.490

2.  Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.

Authors:  Nivedita Arora; Arjun Gupta; Navid Sadeghi
Journal:  BMJ Case Rep       Date:  2017-10-09

3.  Plasmablastic lymphoma of the stomach with C-MYC rearrangement in an immunocompetent young adult: a case report.

Authors:  Xin Huang; Yanping Zhang; Zifen Gao
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 4.  Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

Authors:  Ghaleb Elyamany; Eman Al Mussaed; Ali Matar Alzahrani
Journal:  Adv Hematol       Date:  2015-08-18

5.  Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Muna Aljuboury; Najlah Mogadem; Nagham Rehan; Omar Alsuhaibani; Abdulaziz Alabdulaaly; Eman Al-Mussaed; Imad Elhag; Abdullah AlFiaar
Journal:  Diagn Pathol       Date:  2015-06-25       Impact factor: 2.644

6.  Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review.

Authors:  Chun Cao; Ting Liu; Shifeng Lou; Weiping Liu; Kai Shen; Bing Xiang
Journal:  Oncol Lett       Date:  2014-10-10       Impact factor: 2.967

7.  Mediastinal syndrome from plasmablastic lymphoma in human immunodeficiency virus and human herpes virus 8 negative patient with polycythemia vera: a case report.

Authors:  Massimo Cajozzo; Vincenzo Davide Palumbo; Salvatore Buscemi; Giuseppe Damiano; Ada Maria Florena; Daniela Cabibi; Francesco Raffaele; Antonino Alessio Anzalone; Federica Fatica; Gerlando Cocchiara; Salvatore Dioguardi; Antonio Bruno; Francesco Paolo Caronia; Attilio Ignazio Lo Monte
Journal:  J Med Case Rep       Date:  2017-03-21

8.  Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.

Authors:  Li Lin; Xudong Zhang; Meng Dong; Ling Li; Xinhua Wang; Lei Zhang; Xiaorui Fu; Zhenchang Sun; Jingjing Wu; Zhaoming Li; Yu Chang; Yingjun Wang; Zhiyuan Zhou; Mingzhi Zhang; Qingjiang Chen
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

9.  [Clinical features and outcomes: analysis of 9 cases of HIV-negtive plasmablastic lymphoma].

Authors:  L Gui; X H He; P Liu; J L Yang; Y Qin; S Y Zhou; S Yang; C G Zhang; Y K Shi
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14

10.  Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma.

Authors:  Mehmet Akce; Elaine Chang; Mohammad Haeri; Mike Perez; Christie J Finch; Mark M Udden; Martha P Mims
Journal:  Case Rep Hematol       Date:  2016-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.